empty
 
 
id
Cari
Bantuan
Pembukaan akun instan
Platform Trading
Deposit/Penarikan
Cari
P2P Pertukaran Pasar Keuangan Untuk Kitra Forum Tentang perusahaan
id
Untuk Trader
Grafik
#DVAX

#DVAX (Dynavax Technologies Corporation). Nilai tukar dan grafik online.

#DHR Kembali ke daftar instrumen #DXCM

Konverter mata uang

Dynavax Technologies Corporation
15.49 USD
23 Jan 2026 22:59
Perubahan Harga (% chg)
$-0.04
(-0.26%)
Penutupan Sebelumnya
Penutupan Sebelumnya

Harga penutupan, hari sebelumnya.
$15.63
Buka
Buka

Harga pembukaan.
$15.67
Ketinggian Harian
Ketinggian Harian

Harga tertinggi pada hari transaksi terakhir.
$15.64
Kerendahan Harian
Kerendahan Harian

Harga terendah pada hari transaksi terakhir
$15.49
Kapitalisasi pasar
Kapitalisasi pasar

Nilai total perusahaan dalam pasar saham. Umumnya dihitung dengan menggandakan saham-saham yang beredang dengan harga saham saat itu.
$15.66
Saham Beredar
Saham Beredar

Jumlah saham yang dipegang oleh para investor dan insider perusahaan, diluar sekuritas dilutif (dilutive securities) seperti non-vested RSU dan unexercised options.
$15.49
Unduh arsip
Beli
15.49
Jual
15.49
Buka tabel dalam tampilan layar penuh
Beli
15.49
Jual
15.49
Unduh arsip
Buka tabel dalam tampilan layar penuh

Dynavax Technologies Corporation. About company

Dynavax Technologies Corporation is a biopharmaceutical company whose core business is the development and production of vaccines.

The company’s main product is a hepatitis B drug. The company also produces vaccines against coronavirus, influenza, plague, and other infectious diseases.

In addition, the company is mainly focused on the production of adjuvants. These substances help vaccines to be better absorbed by the body.

Currently, Dynavax has a market capitalization of $1.37 billion. Last year, the company posted revenues of $438.24 million and a net income of $76.71 million.

Dynavax Technologies Corporation’s shares and what affects their price

Dynavax shares have been trading on the NASDAQ exchange under the DVAX ticker since 2004. The initial price per share stood at $7.50.

Currently, the company’s shares are trading between $10 and $12. During the year, the share price was hovering between $7 and $22. At the same time, the company does not pay dividends to its shareholders.

What to pay attention to when trading the company’s shares:

  • Long-term growth prospects are driven by a large number of innovative developments;
  • The target price for the stock is several times higher than the current one, ranging between $45.5 and $48, according to forecasts;
  • Adjuvant technology is an advantage for the company since these additional substances significantly enhance the effect of the vaccines.

Tidak bisa bicara sekarang?
Tanyakan pertanyaan anda lewat chat.